Elgethun Capital Management Abb Vie Inc. Transaction History

Elgethun Capital Management

$361 Million
Q2 2024

A detailed history of Elgethun Capital Management transactions in Abb Vie Inc. stock. As of the latest transaction made, Elgethun Capital Management holds 7,092 shares of ABBV stock, worth $1.4 Million. This represents 0.34% of its overall portfolio holdings.

Number of Shares

7,092

Previous 7,245 2.11%

Holding current value

$1.4 Million

Previous $1.32 Million 7.81%

% of portfolio

0.34%

Previous 0.36%

18 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 13, 2024	SELL	$154.79 - $180.76 $23,682 - $27,656	-153 Reduced 2.11%	7,092 $1.22 Million
Q1 2024 May 13, 2024	BUY	$159.82 - $182.1 $43,311 - $49,349	271 Added 3.89%	7,245 $1.32 Million
Q3 2023 Nov 13, 2023	BUY	$133.59 - $154.65 $3,606 - $4,175	27 Added 0.39%	6,974 $1.04 Million
Q2 2023 Aug 10, 2023	BUY	$132.51 - $164.9 $3,710 - $4,617	28 Added 0.4%	6,947 $935,000
Q1 2023 May 11, 2023	BUY	$144.61 - $166.54 $3,904 - $4,496	27 Added 0.39%	6,919 $1.1 Million
Q4 2022 Feb 10, 2023	BUY	$138.31 - $165.87 $4,564 - $5,473	33 Added 0.48%	6,892 $1.11 Million
Q3 2022 Nov 14, 2022	BUY	$134.21 - $153.93 $154,207 - $176,865	1,149 Added 20.12%	6,859 $920,000
Q2 2022 Aug 12, 2022	BUY	$137.62 - $174.96 $5,504 - $6,998	40 Added 0.71%	5,710 $872,000
Q1 2022 May 11, 2022	BUY	$131.98 - $163.75 $5,543 - $6,877	42 Added 0.75%	5,670 $919,000
Q4 2021 Feb 11, 2022	BUY	$107.43 - $135.93 $5,049 - $6,388	47 Added 0.84%	5,628 $754,000
Q3 2021 Nov 12, 2021	BUY	$106.4 - $120.78 $9,682 - $10,990	91 Added 1.66%	5,581 $602,000
Q2 2021 Aug 13, 2021	BUY	$105.21 - $117.21 $4,839 - $5,391	46 Added 0.84%	5,490 $618,000
Q1 2021 May 14, 2021	BUY	$102.3 - $112.62 $70,689 - $77,820	691 Added 14.54%	5,444 $589,000
Q4 2018 Feb 11, 2019	SELL	$77.85 - $96.01 $6,539 - $8,064	-84 Reduced 1.74%	4,753 $424,000
Q3 2018 Nov 13, 2018	SELL	$88.91 - $98.84 $4,445 - $4,942	-50 Reduced 1.02%	4,837 $461,000
Q2 2018 Aug 10, 2018	SELL	$89.78 - $106.23 $29,178 - $34,524	-325 Reduced 6.24%	4,887 $452,000
Q4 2017 Feb 12, 2018	SELL	$89.56 - $98.21 $20,598 - $22,588	-230 Reduced 4.23%	5,212 $504,000
Q3 2017 Nov 13, 2017	BUY	$69.85 - $89.22 $380,123 - $485,535	5,442	5,442 $484,000

Others Institutions Holding ABBV

# of Institutions

3,695

Shares Held

1.27B

Call Options Held

13M

Put Options Held

9.79M

View Full List

About AbbVie Inc.

Ticker ABBV
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 1,768,099,968
Market Cap $349B
Description
AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...

More about ABBV

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Elgethun Capital Management, based on Form 13F filings with the SEC.

News

Stay updated on Elgethun Capital Management with notifications on news.

Account

Elgethun Capital Management Abb Vie Inc. Transaction History